The U.S. FDA approves Cosentyx® for children 2 years and older.

Avery Henderson shares her nearly 20-year experience living with pustular, plaque, and guttate psoriasis, as well as PsA, and how it guided her choice to tackle medical school.

Apremilast has been approved for mild-to-moderate psoriasis severity.

An expert shares insight into how to distinguish pustular psoriasis and optimize management.

NPF and our fellow scientific community members bid farewell to a great leader and innovative visionary.

Get tips for caring for your scalp psoriasis, including recommended over-the-counter hair products.

Though he is early on in his journey with psoriasis, Austin Tolchin has experienced access to care issues, step therapy-related challenges, and difficult flare ups. Fortunately, things are looking up for this young man.

Offering “byte”-sized medical news updates for health care providers.

This young woman is learning to heal fast and forge ahead, no matter what challenges psoriasis throws her way.

There are resources available to help providers treat patients with skin of color.

Carin Bennett shares her challenges and frustrations with pustular psoriasis and PsA.

Similar symptoms may have you confused, so we talked with an expert about differentiating factors.

The 2021 NPF Research Symposium: Improving Health Outcomes included sections related to clinical, translational, and basic research, as well as guest speakers.

A letter from NPF President and CEO, Randy Beranek.

Two women share how their mental well-being was hit hard by scalp psoriasis, and how volunteering helped them to gain back their confidence.  

Howard Chang is the 2021 NPF Outstanding Volunteer Leader award winner.

There is help available to get the treatment your health care provider has prescribed.

LEXETTE® foam is now available for use in adolescents.

Michelle Racicot used her passion for mountain biking to support those with psoriatic disease.

Dr. Wilson Liao, Chair of the NPF Scientific Advisory Committee, discusses the latest in psoriatic disease research.

This rare type of psoriasis can be difficult to treat and live with, but dermatologists may soon have more effective, targeted therapies.

Newly diagnosed? Want a refresher? Dr. Jason E. Hawkes is here to break down the science of psoriatic disease.

Dr. Christopher Ritchlin is dedicated to educating and empowering this community.